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ABSTRACT 
The ability to generate chiral building blocks is of paramount importance to organic chemists. 
This problem presents itself most notably at the interface of chemistry and biology, where molecules of 
only a single enantiomer can induce function to many biological systems. In this context, recent 
developments in the field of organocatalysis, most notably the employment of chiral N-heterocyclic 
carbenes (NHCs) have shown much promise.  
Our group has recently shown that one possible chiral NHC catalyzed Stetter cyclization product 
of a conjugated triene, a highly functionalized cyclopentenone, contains both a chiral center and an 
adjacent conjugated diene. This structure can be easily elaborated to a bicyclic structural motif present 
in some biologically active natural products from the ginkgolide family, and is difficult to access by other 
means. The synthesis of novel vinyl stannanes and other coupling substrates involved in the 
development of the aforementioned reaction discovery are described in this report. 
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1.     INTRODUCTION (LITERATURE OVERVIEW) 
1.1     Carbenes in Organocatalysis 
The demand for catalytic methods to effect efficient chemical transformations cannot be 
understated. Catalysis offers reduction in waste and expense via sub-stoichiometric amounts of 
reagents. In comparison to the expensive transition metal catalysts pioneered in the early 1970’s, 
organocatalytic methods have received an enormous amount of attention in recent years.1 These 
methods have been shown to be highly efficient for the carbon-carbon bond formations that play such 
an important role in modern organic syntheses. In addition, organocatalyic processes are 
environmentally friendly, selective and easy to use. In this context, much effort has been taken to mimic 
the seemingly effortless methods by which natural biochemical processes occur. One particularly 
pertinent example, the coenzyme thiamine (vitamin B1), utilizes a nucleophilic carbene as its active 
species (Figure 1).2 
 
 
Figure 1. Structure of thiamine (left) and a general carbene species (right) 
Carbenes are the most investigated reactive species in the field of organic chemistry.1  These 
neutral species contain a bivalent carbon atom with only six valence electrons (Figure 1). As a 
consequence of these unique characteristics, many carbenes are highly reactive. Evidence for their 
existence was first discovered by Buchner and Curtis in the late 19th century.3 It was not until the late 
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1980’s that Bertrand and co-workers isolated and characterized the first stable carbene.4 This was 
followed closely by Arduengo et al. in their isolation of a kinetically and thermodynamically stable N-
heterocyclic carbene based on the imidazole moiety (Figure 2).5 
 
 
Figure 2. First stable crystalline carbene prepared by Arduengo et al. 
 
Even before the isolation of the first persistent carbene, thiazolium salts had been known to 
catalyze the condensation of benzaldehyde to benzoin products.6 The umpolung or polarity reversed 
reactivity of aldehydes promoted by a carbene intermediate was proposed by Breslow in 1958.7   
Scheme 1 
 
 
Attack of the nucleophilic carbene on the carbonyl carbon, generates an acyl-anion equivalent 
(Scheme 1). This nucleophilic species (Breslow Intermediate) inverts the normal reactivity of the 
aldehyde. This subsequently promotes nucleophilic attack on an electrophilic species, another 
equivalent of benzaldehyde (Scheme 2). The generation of the 1,2 addition product, an α-
hydroxyketone, also creates a new stereogenic center. 
Scheme 2 
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 In an effort to generate an asymmetric product by this method, an array of novel chiral 
heterazolium carbene precursors have been used with great success.8-10 Enders et al. were the first to 
generate good enantioselectivities for this transformation using their chiral triazolium salt 7 (Figure 3).8 
 
Figure 3. Examples of chiral triazolium carbene precursors 
Besides self condensations, N-heterocyclic carbenes have been used effectively to catalyze cross 
condensations between aldehydes and other various electrophiles including aliphatic or aromatic 
aldehydes11, ketones12, imines13 and even activated double bonds (Stetter reaction).15 
Since its initial discovery in 1976, the Stetter reaction has evolved into one of the most 
important procedures for the synthesis of 1,4-dicarbonyl compounds.15 This transformation consists of a 
nucleophile catalyzed conjugate addition of an aldehyde to a Michael accepter such as an enone. The 
active catalyst is a thiazolium, imidazolium or triazolium salt, which forms a N-heterocyclic carbene in 
situ upon deprotonation (Figure 4). In addition to intermolecular Stetter products, intramolecular 1,4-
additions have the ability to form highly functionalized cyclic products. 
Enders and co-workers were the first to report an asymmetric variant of the intramolecular 
Stetter reaction using chiral triazolium salts.16 This facet was later expounded upon most notably by 
Rovis et al., in their design and functional assessment of polycyclic pyrrolidine and aminoindanol-derived 
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triazolium salts.17 He successfully showed in subsequent reports that these catalyst frameworks were 
versatile and suitable for a variety of other asymmetric Stetter-type transformations.18 The 
aforementioned catalysts of type 4 and 5 (Figure 3) have proved exceptional in generating some 
products in excellent enantioselectivies. The multiple applications of these privileged NHC’s has 
prompted much investigation in the scientific community and consequently the number of asymmetric 
transformations mediated by N-heterocyclic carbenes is growing by the day.19 
 
1.2     Discovery of a Novel Asymmetric Stetter Cyclization 
Our group was initially interested in solving an elusive problem faced by synthetic chemists, the 
selective catalysis of triene cyclizations. Conjugated trienes can contain many unique functional groups 
and their cyclic derivatives could prove to be useful synthetic intermediates. Inspired by the results by 
Rovis involving intramolecular Stetter reactions17-18, we hypothesized that a catalytic amount of 
chiral NHC could be employed to facilitate an asymmetric triene cyclization provided that the 
substrates possessed suitable reactivities.  
             
A preliminary study by Guansai Liu, involving activated triene 2 (Equation 1) showed great 
promise in converting the acyclic substrate to the corresponding cyclopentenone 3. This method 
employed the use of an aminoindanol-derived triazolium salt 1 as catalyst and generated this unique 
product with high enantioselectivity (>97 % ee). The proposed catalytic cycle is shown in Figure 4. 
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Figure 4. Proposed Catalytic Cycle. Chiral aminoindanol derived triazolium salt 1, is deprotonated upon addition of base to 
generate active carbene species 2. Nucleophilic attack of carbene on aldehyde generates intermediate 3, followed by proton 
transfer to form enol 4. Equilibration with breslow intermediate 5, forms an acyl-anion, which readily undergoes intramolecular 
attack on the Michael acceptor to form cyclic intermediate 6. Intermolecular proton transfer yields species 7, which readily 
equilibrates to form 8, followed by reformation of the carbonyl and release of active catalyst. 
6 
 
 
                          
This previously unreported structure contains an enantio-enriched quaternary steriogenic 
center and an adjacent conjugated diene, thus can be a useful synthetic intermediate for further 
transformations. The immediate synthetic application of this discovery later became apparent after 
following a two-step transformation, to deliver enantiopure bicyclic lactone (Equation 2). This bicyclic 
moiety can be identified in a variety of biologically active natural products in the ginkgolide family.20 
 
Figure 5. Structure of ginkgolide B 
Terpenelactones such as ginkgolide B (Figure 5) have been established as potent PAF receptor 
antagonists.21 Platelet-activating factor (PAF) is an important factor for inflammation and a mediator of 
bronchoconstriction in the body, stressing the value of new synthetic routes towards their structural 
analogs.22 In addition, ginkgolide natural products have been shown to inhibit neurotoxicity of amyloid-β 
plaques that are responsible for Alzheimer’s disease.23 The aforementioned structure 4 is difficult to 
access by other means (Equation 2). In addition, the enatio-pure bicyclic allylic halides are versatile 
intermediates for further transformations and may prove useful in future drug discovery and natural 
product total syntheses.  
1.3     Synthesis of Conjugated Trienes 
To fully realize the overall scope and relevancy of this reaction discovery, a variety of substrate 
trienes with different steric and electronic properties were needed. Ideally the product triene would 
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have a formyl group at the 5’-position and a Michael acceptor at the 1’ carbon to direct the Stetter 
cyclization towards its β carbon. It was already known that methyl or ethyl ester would be sufficient to 
activate the double bond at that position.24 The incorporation of aliphatic and aromatic substituents 
positioned along the polyene chain must also be tolerated (Figure 6).  The route chosen to procure the 
desired conjugated trienes was to link them together in a series of coupling reactions. 
Since the geometry of the conjugated double bonds could play a significant role in the outcome 
of a successful result, the synthetic steps were designed after procedures known to maximize the yield 
of select isomers. It was determined that a geometrically defined (2E, 4Z, 6E) hepatriene could be 
prepared by Stille coupling of a vinyl stannane and a (2E, 4Z) vinyl iodide, and formerly the vinyl iodide 
could be prepared by a Witteg reaction from a (2E) vinyl aldehyde and methyltriphenylphosphonium 
iodide (Scheme 3). 
Scheme 3 
 
 
2. SYNTHESIS OF COUPLING SUBSTRATES 
 
2.1 Synthesis of Vinyl Stannanes 
 
 The earliest work focused on procuring of a variety of aryl vinyl stannanes with different 
electronic properties. When finally coupled to form a conjugated triene, these properties would be used 
to tune the reactivity and define the overall scope of the asymmetric cyclization reaction. Both electron 
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withdrawing and some moderately donating groups on the aromatic ring were sought after. The starting 
material moiety was determined by cost factor as derivatives of cinnamaldehyde. Many of these 
compounds were known and a few were commercially available. Those that were not readily available 
were synthesized from their corresponding benzaldehyde derivative via Aldol condensation with 
acetaldehyde in MeOH and strong base such as KOH (Equation 3). 
     
This procedure was adequate for moderately donating groups 1a, 2a, and 5a (Scheme 4) but 
proved too reactive when applied to substrates with strong electron withdrawing capabilities. A 
modified procedure was developed to use a slightly weaker base (DBU) and by decreasing the reaction 
time period. This proved adequate to furnish the desired products 3a, 4a and 6a in acceptable yields. 
Scheme 4 
 
The α,β-unsaturated aldehydes 1a-6a (Scheme 2) were next converted to their corresponding 
vinyl iodide. Dimethylaminopyridine (DMAP) catalyzed a mild vinylic halogenation in aqueous THF. This 
procedure proved effective for all the substrates investigated and led to the desired α-iodoaldehydes 
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1b-6b in moderate yield.  A facile acetal protection of compounds 1b-6b via triethylorthoformate in 
refluxing EtOH delivered the desired products 1c-6c in excellent yields. All unreported compounds were 
fully characterized before use in subsequent steps. 
       
The next step was done concurrently with Jing Huang. Compounds 1c - 6c were lithiated by n-
BuLi to displace iodine, then the corresponding organolithium reagent was used in situ. A solution of 
Bu3SnCl was added dropwise to the reaction mixture and stirred overnight at -78 
oC. Due to their liable 
nature vinyl stannanes 1d-6d were not fully purified or characterized, instead the crude coupling 
substrates were used directly in the Leibskind modified Stille coupling procedure reported by Xu et al.26 
 
2.2 Synthesis of Vinyl Iodides 
 
This work focused on procuring of a variety of ethyl ester substituted (2E, 4Z) vinyl iodides with 
different steric and electronic properties. When finally coupled to form a conjugated triene, these 
functional groups would be used to help tune the reactivity and define the overall scope of the 
asymmetric cyclization reaction. 
Both aliphatic and aromatic 3’- substituted (2E) 4-oxobut-2-enoates, were desired. As Wilkerson, 
P. began synthesis aromatic derivatives, work began on an ethyl (2E) 3-ethyl -4-oxobut-2-enoate, 
compound 14. 
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For the synthesis of ethyl (2E) 3-ethyl -4-oxobut-2-enoate, compound 14, a novel procedure had 
to be developed.  It was hypothesized that ethyl glyoxylate could cross condense with butyraldehyde via 
a proline catalyzed Aldol condensation, followed by dehydration to yield the desired vinyl aldehyde. An 
initial procedure was developed using a catalytic amount L-proline in DCM at 0 oC that yielded the 
desired product in acceptable yield without the need for dehydration. Before this discovery, compound 
14 had never been synthesized by this method and although it is reported as a byproduct from another 
mechanism (REF), has never been fully characterized until now. Compound 14 was also taken one step 
further by reaction with a previously prepared methyltriphenylphosphonium iodide Witteg reagent in 
dry THF at -78 oC to furnish the previously unreported compound 15 in moderate yield and good 
diastereoselectivity - 10:1/Z:E. 
3. RESULTS 
The array of novel vinyl stannanes and vinyl iodides were passed on to Guansai Liu, to form 
fourteen distinct substrate variants. A Liebeskind modified Stille coupling procedure was adopted that 
involved Pd(PPh3)4 catalyst and CuTC, to join distinct vinyl tin and vinyl iodides together. These 
compounds were then de-protected to generate the reactive conjugated trienes in good yield. These 
substrates were then successfully applied in the novel asymmetric Stetter cyclization reaction.26 
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4.    CONCLUSION 
An efficient one step procedure for the synthesis of (E)-ethyl 3-formylpent-2-enoate from 
commercially available starting materials has been developed herein. The absolute configuration was 
determined by NOESY 2-D NMR. This procedure has not been fully optimized and may prove useful in 
the development of other 3’ substituted (E)-ethyl 4-oxobut-2-enoates. These vinyl aldehydes are useful 
synthetic intermediates for a variety of transformations. One example used herein, the Stork-Zhao 
Witteg Olefination method25 generated the corresponding ethyl (2E, 4Z)-3-ethyl-5-iodopenta-2, 4-
dienoate in good yield and selectivity. These vinyl iodides may prove useful in cross-coupling reactions 
such as Suzuki-Miyaura, Stille, and Heck coupling.  A series of novel aromatic vinyl tin compounds were 
also synthesized and fully characterized herein. These compounds were successfully applied in a Stille 
coupling reaction by Xu et al. to generate conjugated trienes 26 and may prove useful in other Stille type 
transformations. 
5.     EXPERIMENTAL 
5.1    General 
All solvents used were dehydrated by an SG Water solvent drying system. All reagents were 
purchased from Sigma Aldrich and used without further purification unless otherwise noted. Glassware 
was either flame dried under vacuum or dried in an oven at 120 oC, assembled hot under a continuous 
argon atmosphere and capped with a rubber septum. 1H NMR and 13C NMR spectra were obtained in 
CDCl3 at 27 ˚C on a Bruker 400 MHz instrument. Chloroform peaks for 
1H NMR and 13C NMR spectra 
were referenced at 7.27 and 77.0 ppm respectively. All final products were fully characterized by 1H 
NMR, 13C NMR, mass spectrometry, and infrared spectroscopy. 
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5.2    Synthesis of Vinyl Tin Compounds 
General procedure for the preparation of (2E)-(3-phenyl-substituted)-prop-2-enals 1a-6a 
 
To a solution of substituted benzaldehyde (100 mmol) and acetaldehyde (150 mmol) at 0 oC, 
KOH (110 mmol) in MeOH (250 mL) was added dropwise via gradutated addition funnel over the course 
of several hours. This solution was allowed to warm to RT over 12 h. The solution was quenched by 0.1 
M HCl and extracted with DCM. The combined organic layers were dried over Na2SO4 and the solvent 
removed in vacuo. Column chromatography on silica gel (pure DCM) afforded products 1a, 2a and 5a in 
moderate (40-55%) yield. 
Compounds 3a, 4a and 6a, were prepared as previously described with slight modifications. To a 
solution of substituted benzaldehyde (35 mmol) and acetaldehyde (40 mmol) at 0 oC, DBU (70 mmol) 
was added dropwise and the solution stirred for 1 h. This solution was allowed to warm to room 
temperature over the course of 4 h after which the solution was quenched with 0.1 M HCl and extracted 
with DCM. The combined organic layers were dried over Na2SO4 and the solvent removed in vacuo. 
Column chromatography on silica gel (pure DCM) afforded products in (35-40%) yield, all spectra agreed 
with reported data. 
 General procedure for synthesis of (Z)-2-iodo-(phenyl-substituted)acrylaldehydes 1b-6b 
 
Compounds were prepared by dissolving α,β- unsaturated aldehyde 1a-6a (1 mmol) in a mixture 
of THF/H2O (5 mL, 1:1). K2CO3 (0.17 g, 1.2 mmol), iodine (0.38 g, 1.5 mmol) and DMAP (0.024 g, 0.2 
mmol) were added in succession. The reaction mixture was stirred at RT for 24 h, then diluted with DCM 
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and washed with saturated Na2S2O3. The combined organic layers were dried over Na2SO4, filtered and 
the solvent was removed in vacuo. Column chromatography on silica gel (hexanes : DCM = 1:2) afforded 
product α-iodoaldehydes in (50-70%) yield. 
 General procedure for acetal protection of α-iodoaldehydes 1c-6c 
 
To a solution of (2Z)-2-iodo-(3-phenyl-substituted)-prop-2-enal, 1b-6b (2 mmol) and 
triethylorthoformate (0.2 mL, 1.2 mmol) in EtOH (2 mL) was added a catalytic amount of NH4Cl (4.3 mg, 
0.08 mmol). The resultant mixture was stirred under reflux until all the starting material was consumed 
as monitored by TLC. The solvent was then removed in vacuo, column chromatography on silica gel 
(hexanes : EtOAc : Et3N = 1 : 4 : 0.2) afforded product in (90-98%) yield. 
 
General procedure for the synthesis of vinyl stannanes 1d-6d 
 
To a flame dried flask was charged vinyl iodide 1c-6c (3 mmol) and Et2O (35 mL). The resultant 
solution was cooled to -78 oC and n-BuLi (2.5 M in hexanes, 1.4 mL, 3.3 mmol) was added dropwise. The 
reaction mixture was stirred for 10 min and Bu3SnCl (0.9 mL, 3.3 mmol) was added dropwise. After 
stirring for an additional 2 h at -78 oC, H2O (2 mL) was added to quench the reaction. The organic 
solution was washed with H2O, brine, dried over Na2SO4, filtered and concentrated in vacuo. Column 
chromatography by a short silica gel column (hexanes : Et3N = 19 : 1) afforded vinyl tin compound that 
was found adequate to allow progression to the next step without further purification (83-91%). 
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5.2 Synthesis of Vinyl Iodides 
General Procedure for the Synthesis of Vinyl Aldehydes via Proline Catalyzed Aldol Condensation 
 
To a solution of butyraldehyde (1 mmol) in dry DCM (10 mL) was added ethyl glyoxylate (50% in 
toluene, 2.5 mmol) and L-proline (0.5 mmol). The resultant solution was cooled to 0 oC and DBU (1.1 
mmol) was added dropwise. The mixture was stirred for 1 h then allowed to warm to RT and stirred for 
an additional 2 h. The organic solution was washed with H2O and the combined organic layers dried over 
Na2SO4 before being concentrated in vacuo. Column chromatography by a short silica gel column 
(hexanes : EA = 20 : 1) afforded product 14 in (42%) yield. 
 
General Procedure for the Synthesis of (2E, 4Z) Vinyl Iodides via Stork-Zhao Witteg Olefination25 
 
To a flame-dried round bottom flask was charged THF (15 mL) and (iodomethyl) 
triphenylphosphonium iodide (1.6 g, 3 mmol). NaHMDS (1.0 M in THF, 3.0 mL, 3 mmol) was added 
dropwise at RT. After the solid was dissolved, the solution was stirred for an additional 10 min then 
cooled to -60 oC. HMPA (3.8 mmol) was added dropwise. The reaction mixture was cooled to -78 oC and 
stirred for 15 min. Vinyl aldehyde 14 (2.5 mmol) in THF (10 mL) was added dropwise and the reaction 
mixture was allowed to stir for 30 min. Hexanes (50 mL) was added to quench the reaction and the 
resultant suspension was filtered through celite. The filtrate was washed by H2O x 5 (25 mL) and brine. 
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The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Column 
chromatography on silica gel (hexanes : EtOAc = 20 : 1) afforded vinyl iodide 15 (Z/E = 10/1) in (55-60%) 
yield. 
 
5.4 Compound Characterization 
 
(E)-3-(p-tolyl)acrylaldehyde (1a): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 9.71 (d, J 
= 7.6 Hz, 1H), 7.46 (d, J = 2.5 Hz, 2H), 7.43 (d, J = 16 Hz, 1H), 7.24 (d, J = 8 Hz, 2H), 6.72 (dd, J = 7.6, 16 Hz, 
1H), 2.39 (s, 3H) 
 
(E)-3-(4-methoxyphenyl)acrylaldehyde (2a): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 9.64 
(d, J = 7.6 Hz, 1H), 7.52 (d, J = 8 Hz, 2H), 7.42 (d, J = 16 Hz, 1H) 6.94 (d, J =8 Hz, 2H), 6.60 (dd, J = 7.6, 16 
Hz, 1H) 3.86 (s, 3H) 
 
(E)-3-(3-chlorophenyl)acrylaldehyde (3a): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 8.61 (d, J 
= 7.5 Hz, 1H), 7.28-7.44 (m, 5H), 6.60 (dd, J = 16, 7.5 Hz, 1H) 
 
(E)-3-(4-bromophenyl)acrylaldehyde (4a): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 9.71 (d, J 
= 7.5 Hz, 1H), 7.57 (d, J =8.5 Hz, 1H), 7.45–7.40 (m, 3H), 6.70 (dd, J = 16.0, 7.5 Hz, 1H) 
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(E)-3-(benzo[d][1,3]dioxol-5-yl)acrylaldehyde (5a): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 
9.65 (d, J = 7.6 Hz, 1H) 7.38 (d, J = 16.0 Hz, 1H), 7.06-7.08 (m, 2H), 6.86 (d, J = 8.8 Hz, 1H), 6.56 (dd, J = 
16.0, 7.6 Hz, 1H) 6.05 (s, 2H) 
 
(E)-3-(4-chlorophenyl)acrylaldehyde: known compound: 1H NMR (400 MHz, CDCl3) δ ppm 9.70 (d, J = 
7.6 Hz, 1H), 7.52−7.40 (m, 5H), 6.68 (dd, J = 16.0 Hz, 7.6 Hz, 1H) 
 
 
 (Z)-2-iodo-3-p-tolylacrylaldehyde (1b): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 8.76 (s, 1 
H), 8.06 (s, 1 H), 8.95 (d, J = 12.0 Hz, 2 H), 7.30 (d, J = 8.0 Hz, 2 H) 
 
(Z)-2-iodo-3-(4-methoxyphenyl)acrylaldehyde (2b): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 
8.74 (s, 1 H), 8.09 (d, J = 8.0 Hz, 2 H), 8.04 (s, 1 H), 7.02 (d, J = 8.0 Hz, 2 H), 3.89 (s, 3 H) 
 
(Z)-3-(3-chlorophenyl)-2-iodoacrylaldehyde (3b): 1H NMR (400 MHz, CDCl3) δ ppm 8.80 (s, 1 H), 8.04 (s, 
1 H), 7.99 (s, 1 H), 7.86 (d, J = 7.6 Hz, 1 H), 7.55–7.38 (m, 2 H); 13C NMR (100 MHz, CDCl3): 188.7, 153.9, 
135.9, 131.3, 129.9, 128.3, 107.7 ; IR (film) νmax, 3065 (w), 2827 (m), 1685 (s), 1587 (m), 1559 (m), 1469 
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(m), 1412 (m), 1265 (m), 1204 (m), 1086 (s) cm-1; HRMS (ESI-TOF) for C9H3O3I [M + H+] calculated 
292.9230, found 292.9233 
 
(Z)-3-(4-bromophenyl)-2-iodoacrylaldehyde (4b): m.p. 105–107 ºC; 1H NMR (400 MHz, CDCl3) δ ppm 
8.78 (s, 1 H), 8.03 (s, 1 H), 7.88 (d, J = 12.0 Hz, 2 H), 7.63 (d, J = 8.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3): 
188.8, 154.2, 133.0, 132.0, 131.7, 126.1, 106.8; IR (film) νmax, 2829 (w), 1674 (s), 1595 (m), 1579 (s), 
1557 (m), 1485 (m), 1407 (m), 1278 (m), 1078 (s), 1091 (s) cm-1; HRMS (ESI-TOF) for C9H7OBrI [M + 
H+] calculated 336.8725, found 336.8735 
 
(Z)-3-(benzo[d][1,3]dioxol-5-yl)-2-iodoacrylaldehyde (5b): 1H NMR (400 MHz, CDCl3) δ ppm 8.73 (s, 1 H), 
7.98 (s, 1 H), 7.85 (s, 1 H), 7.46 (dd, J = 8.0, 4.0 Hz, 2 H), 6.92 (d, J = 8.0 Hz, 2 H), 6.08 (s, 2 H); 13C NMR 
(100 MHz, CDCl3): 189.0, 155.2, 150.84, 147.83, 128.07, 128.04, 109.4, 108.6, 102.93, 102.0; IR (film) 
νmax, 2923 (s), 2853 (m), 1679 (s), 1572 (s), 1501 (s), 1486 (s), 1449 (s), 1361 (m), 1314 (w), 1255 (s), 
1090 (s), 1035 (s) cm-1; HRMS (ESI-TOF) for C9H3O3I [M + H+] calculated 302.9518, found 302.9576 
 
(Z)-3-(4-chlorophenyl)-2-iodoacrylaldehyde (6b): known compound: 1H NMR (400 MHz, CDCl3) δ ppm 
8.81 (s, 1 H), 8.07 (s, 1 H), 7.98 (d, J = 8.8 Hz, 2 H), 7.50 (d, J = 8.8 Hz, 2 H) 
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(Z)-1-(3,3-diethoxy-2-iodoprop-1-enyl)-4-methylbenzene (1c): 1H NMR (400 MHz, CDCl3) δ ppm 7.52 (d, 
J = 8.0 Hz, 2 H), 7.27 (d, J = 4.0 Hz, 1 H), 7.18 (d, J = 8.0 Hz, 2 H), 4.72 (s, 1 H), 3.70–3.56 (m, 4 H), 2.36 (s, 
3 H), 1.29 (t, J = 8.0 Hz, 6 H); 13C NMR (100 MHz, CDCl3): 138.4, 136.2, 133.6, 128.80, 128.76, 105.1, 
103.8, 61.9, 21.4, 15.1; IR (film) νmax, 3057 (w), 2975 (m), 2928 (w), 2878 (m), 1480 (w), 1445 (m), 1329 
(m), 1116 (s), 1055 (s) cm-1; HRMS (ESI-TOF) for C14H19O2INa [M + Na+] calculated 369.0328, found 
369.0313 
 
(Z)-1-(3,3-diethoxy-2-iodoprop-1-enyl)-4-methoxybenzene (2c): 1H NMR (400 MHz, CDCl3) δ ppm 7.64 
(d, J = 12.0 Hz, 2 H), 6.92 (d, J = 8.0 Hz, 1 H), 4.71 (s, 1 H), 3.84 (s, 3 H), 3.71–3.57 (m, 4 H), 1.30 (t, J = 8.0 
Hz, 6 H); 13C NMR (100 MHz, CDCl3): 159.7, 135.7, 130.4, 128.0, 113.4, 105.2, 102.4, 61.9, 55.2, 15.1; IR 
(film) νmax, 2829 (w), 1674 (s), 1595 (m), 1579 (s), 1557 (m), 1485 (m), 1407 (m), 1278 (m), 1078 (s), 
1091 (s) cm-1; HRMS (ESI-TOF) for C14H19O3INa [M + Na+] calculated 385.0277, found 385.0267 
 
(Z)-1-chloro-3-(3,3-diethoxy-2-iodoprop-1-enyl)benzene (3c): 1H NMR (400 MHz, CDCl3) δ ppm 7.58 (s, 1 
H), 7.48–7.46 (m, 1 H), 7.33–7.28 (m, 3 H), 4.79 (s, 1 H), 3.73–3.58 (m, 4 H), 1.31 (t, J = 7.2 Hz, 6 H); 13C 
NMR (100 MHz, CDCl3): 138.7, 135.1, 129.4, 128.8, 128.3, 127.0, 106.5, 104.8, 62.0, 15.1; IR (film) νmax, 
2976 (m), 2919 (m), 1593 (w), 1564 (w), 1473 (m), 1119 (s), 1061 (s) cm-1; HRMS (ESI-TOF) for 
C13H16O2ClINa [M + Na+] calculated 388.9781, found 388.9772 
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(Z)-1-bromo-4-(3,3-diethoxy-2-iodoprop-1-enyl)benzene (4c): 1H NMR (400 MHz, CDCl3) δ ppm 7.51–
7.45 (m, 4 H), 7.24 (s, 1 H), 4.75 (s, 1H), 3.72–3.54 (m, 4 H), 1.28 (t, J = 8.0 Hz, 6 H); 13C NMR (100 MHz, 
CDCl3): 135.6, 135.2, 131.3, 130.4, 9 122.4, 105.7, 104.8, 62.0, 15.1; IR (film) νmax, 2974 (m), 2928 (w) 
2878 (m), 1485 (m), 1396 (m), 1329 (m), 1115 (s), 1048 (s), 1009 (s) cm-1; HRMS (ESI-TOF) for 
C13H16O2BrINa [M + Na+] calculated 432.9276, found 432.9266 
 
(Z)-5-(3,3-diethoxy-2-iodoprop-1-enyl)benzo[d][1,3]dioxole (5c): 1H NMR (400 MHz, CDCl3) δ ppm 7.28 
(s, 1 H), 7.20 (s, 1 H), 7.05 (d, J = 8.0 Hz, 1 H), 6.81 (d, J = 8.0 Hz, 1 H), 5.99 (s, 1 H), 4.70 (s, 1 H), 3.69–
3.54 (m, 4 H), 1.28 (t, J = 8.0 Hz, 6 H); 13C NMR (100 MHz, CDCl3): 146.3, 135.7, 123.7, 108.7, 108.0, 
105.2, 103.1, 101.2, 61.9, 15.1; IR (film) νmax, 2977 (m), 2888 (m), 2247 (w), 1605 (w), 1504 (m), 1489 
(s), 1445 (m), 1259 (m), 1117 (m), 1059 (s), 1041 (s) cm-1; HRMS (ESI-TOF) for C14H17O4INa [M + Na+] 
calculated 399.0069, found 399.0061 
 
(Z)-1-chloro-4-(3,3-diethoxy-2-iodoprop-1-enyl)benzene(6c): 1H NMR (400 MHz, CDCl3) δ ppm 7.55 (d, J 
= 8.8 Hz, 2 H), 7.36 (d, J = 8.0 Hz, 2 H), 7.29 (s, 1 H), 4.78 (s, 1 H), 3.74–3.56 (m, 4 H), 1.31 (t, J = 7.2 Hz, 6 
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H); 13C NMR (100 MHz, CDCl3): 135.16, 135.15, 134.17, 130.2, 128.3, 105.7 104.9, 62.0, 15.1 ; IR (film) 
νmax, 2976 (m), 2928 (w), 2879 (m), 1593 (m), 1564 (m), 1473 (m), 1409 (w), 1333 (w), 1257 (w), 1116 
(s), 1055 (s) cm-1; HRMS (ESI-TOF) for C13H16O2ClINa [M + Na+] calculated 388.9781, found 388.9777 
 
ethyl (2E)-formylpent-2-enoate (14): 1H NMR (400 MHz, CDCl3) 9.52 (s, 1H), 6.44 (s, 1H), 4.31-
4.26 (q, J = 7 Hz, 2H), 2.73-2.67 (q, J = 7.6 Hz, 2H), 1.35 (t, J = 7.0 Hz, 3H), 1.05 (t, J = 8 Hz, 3H); 13C NMR 
(100 MHz, CDCL3): 194.34, 165.24, 155.8, 135.2, 61.05, 18.3, 14.1, 13.15; HRMS (ESI-TOF) for C8H13O3[M 
+ H+] calculated 157.0865, found 157.0863 
 
ethyl (2E, 4Z)-3-ethyl-5-iodopenta-2, 4-dienoate (15)( Z/E = 10/1): 
1H NMR (400 MHz, CDCl3) δ ppm 6.73 
(d, J = 8.8 Hz, 1H), 6.60 (d, J = 8.8 Hz, 1H) 5.98 (s, 1H), 4.23-4.18 (q, J = 7.1 Hz, 2H), 2.81-2.75 (q, J = 7.6 
Hz, 2H), 1.31 (t, J = 7.24 Hz, 3H), 1.09 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCL3): 166.0, 157.65, 140.1, 
119.1, 82.64, 60.0, 24.34, 14.25, 12.73; HRMS (ESI-TOF) for C9H14O2I [M + H+] calculated 281.0039, found 
281.0029 
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